期刊文献+

甲状腺瘤组织中糖皮质激素受体-αmRNA的表达 被引量:3

Detection of glucocorticoid receptor-α mRNA expression in thyroid adenomas
原文传递
导出
摘要 目的检测糖皮质激素受体-α(GR-α)mRNA在甲状腺瘤和甲状腺正常组织中的定量表达,并探讨其在甲状腺瘤发生发展中的意义。方法我院住院手术治疗的22例甲状腺瘤患者。提取甲状腺瘤和甲状腺正常组RNA,应用实时荧光定量逆转录PCR(FQ-RT-PCR)检测GR-αmRNA定量表达。结果GR-α在甲状腺正常组织中(15.2±5.0)×105拷贝/μg比甲状腺瘤甲状组织中(2.4±4.9)×105拷贝/μg表达高,两组之间有明显差异(P<0.05)。结论正常甲状腺组织中存在糖皮质激素受体-αmRNA表达,生理量的糖皮质激素受体-α的基因效应减弱,可能是促进甲状腺瘤的发生发展的一个重要方面。 Objective To detect the expression of glucocorticoid receptor-α (GR-α) mRNA in thyroid adenomas and thyroid gland tissues and its role in the development of thyroid adenomas. Methods By using fluorescent quantitative PCR(FQ-RT-PCR), the expression of GR-α mRNA was detected in 22 previously diagnosed cases of thyroid adenomas and thyroid gland tissues. Results GR-α mRNA levels in the normal thyroid were significantly higher than in thyroid adenomas (P 〈 0.05). Conclusion GR-α was detectable in the thyroid adenoma and thyroid gland tissues. A downregulation of GR-α mRNA in thyroid adenoma seems to suggest that glucocorticoid is likely to play an important role in the developmerit of thyroid adenomas.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2005年第11期1311-1312,共2页 Chinese Journal of Experimental Surgery
基金 国家教委博士基金资助项目(21030558080) 广东省科技计划项目(2003C30309)
  • 相关文献

参考文献2

  • 1Kinyamu HK,Archer TK.Estrogen receptor dependent proteasomal degradation of the glucocorticoid recptor is coupled to an increase in mdm2 protein expression.Mol Cell Bol,2003,23:5867-5881.
  • 2Buttgereit F,Wehling M,Burmester GR.A new hypothesis of modular glucocorticoid actions:steroid treatment of rheumatic diseases revisited.Arthritis Rheum,1998,41:761-767.

同被引文献24

  • 1张孝文,李鹏,李源,刘贤,张革化,叶进.糖皮质激素受体-α mRNA在腮腺多形性腺瘤中的定量检测[J].中国耳鼻咽喉头颈外科,2005,12(11):741-742. 被引量:2
  • 2林意玲,吴平,廖海兰,张培华,何惠娟,江黎明,梁念慈.半边旗二萜类化合物5F对人翼状胬肉成纤维细胞结缔组织生长因子表达和胶原合成的影响[J].中山大学学报(医学科学版),2006,27(4):369-373. 被引量:2
  • 3李永平,朱哲,张文忻,刘琳,梁丹.翼状胬肉纤维组织起源于间充质干细胞的证据[J].中山大学学报(医学科学版),2007,28(2):127-130. 被引量:11
  • 4Al-Ghamdi SA,Manoukian JJ,Morielli A,et al.Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotonsillar hypertrophy? Laryngoscope,1997,107:1382-1387.
  • 5Brouillette RT,Manoukian JJ,Ducharme FM,et al.Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea.J Pediatr,2001,138:838-844.
  • 6Criscuoli G,D'Amora S,Ripa G,et al.Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone.Pediatrics,2003,111:e236-238.
  • 7Reichardt HM,Tuckermann JP,Bauer A,et al.Molecular genetic dissectional of glucocorticoid receptor function in vivo.Z Rheumatol,2000,59 (Suppl 2):Ⅱ/1-5.
  • 8Goldbart AD,Veling MC,Goldman JL,et al.Glucocorticoid receptor subunit expression in adenotonsillar tissue of children with obstructive sleep apnea.Pediatr Res,2005,57:232-236.
  • 9Messner AH,Pelayo R.Pediatric sleep-related breathing disorders.Am J Otolaryngol,2000,21:98-107.
  • 10Rosen CL.Obstructive sleep apnea syndrome (OSAS) in children:diagnostic challenges.Sleep,1996,19 (Suppl):S274-277.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部